Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia

Lancet. 1981 Jun 20;1(8234):1368. doi: 10.1016/s0140-6736(81)92544-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cholestyramine Resin / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*
  • Male
  • Middle Aged
  • Phenols / administration & dosage*
  • Probucol / administration & dosage*

Substances

  • Phenols
  • Cholestyramine Resin
  • Probucol